Microsclerotherapy Treatment Market is expanding as Diomed Holdings Inc. received regulatory approval from Health Canada for its EndoVenous Laser Treatment (EVLT) laser system to treat varicose veins
Microsclerotherapy is a form of
treatment that is used for the treatment of small wounds. The small wounds may
range from mild irritations to deep surgical wounds. Microsclerotherapy has the
ability to heal through a blood vessel to help with larger wounds. The
applications for Microsclerotherapy vary greatly depending on the type of wound
that you are treating, what you are trying to heal, how large the wound is,
etc. Rising cases of Varicose veins and spider veins remain one of the major
health issues. Spider veins refer to small, damaged veins that can appear on
the surface of the legs or face. As per the American Society of Dermatology
Surgery (ASDS), over 40% of women have some form of varicose vein condition
including spider veins. As per the same source, around 80% of women have some
form of venous disease by the age of 80 years. Microsclerotherapy treatment can
be effective in eliminating varicose veins. Hence, such factors can stimulate
growth of the microsclerotherapy treatment market.
When it comes to geographical impact,
North America seems to be gaining significant traction in the regional microsclerotherapy
treatment market. This is due to the fact that there is high importance
for aesthetics as well as a rise in the prevalence of spider veins in the said
region. On the contrary, Asia Pacific is exhibiting promising signs in terms of
the adoption of microsclerotherapy treatment since there has been a rise in
awareness among patients.
Recently, in March 2020, Diomed
Holdings Inc. received regulatory approval from Health Canada for its
EndoVenous Laser Treatment (EVLT) laser system to treat varicose veins.
However, certain challenges in the
adoption of microsclerotherapy treatment can have a negative impact on growth
of the market. Factors such as side effects of the said treatment remain one of
the major hurdles in the market growth. Besides, high treatment costs can
potentially impede growth of the microsclerotherapy treatment market.
Global Microsclerotherapy Treatment
sector is expected to grow at a rapid rate due to the increasing number of
people diagnosed with chronic non-inflammatory diseases like diabetes, cardiac
syndromes, and various other respiratory infections throughout the globe. Over
the years microsclerotherapy treatment has improved significantly with the
advent of new medical devices. Key companies are focused on continuous research
and development activities, in order to offer non-invasive medical devices.
Hence, such factors can potentially augment growth of the microsclerotherapy
treatment market in the near future.

Comments
Post a Comment